Moderna invested heavily in manufacturing during the pandemic to meet high demand for its Covid vaccine. The company has been reducing capacity as demand for the shot falls. Last month ...
US scientists have discovered an alarming syndrome linked to the most commonly used Covid jab in the UK as the number of ...
Moderna's total revenue for the fourth quarter fell nearly 66% to $966 million, but beat analysts' expectations of $942.84 million. Most of those sales were generated by the COVID shot ...
Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, a person close to the matter told Fierce Pharma. The layoffs are ...
US scientists have discovered an alarming syndrome linked to the most commonly used Covid jab in the UK as the number of ...
Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster ... or another bivalent shot from rival Moderna – also approved ...
A local resident receives the Moderna COVID-19 vaccine shot at a center, June 30, 2021, in the Sumida ward of Tokyo. (Eugene Hoshiko / AP) NEW YORK - The Central Intelligence Agency has assessed ...
COVID-19 has impacted nearly every aspect of life. Although tens of thousands of cases continue to occur each week, the world ...
At its update, Moderna highlighted its next-generation COVID-19 vaccine and respiratory syncytial virus (RSV) shot mRNA-1345, as well as a series of candidates for latent viruses, including ...
2025 Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending its shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback